Considerations To Know About D-F07
Participant has had another prior or concurrent malignancy inside of two years prior to enrollment with the following exceptions: adequately dealt with localized basal cell or squamous cell carcinoma, or curatively treated in situ carcinoma with the cervix or breast. Other exceptions might be regarded upon sponsor consultation.As such, NV-5138 will